PT  - JOURNAL ARTICLE
AU  - Filippini, Graziella
TI  - Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate
AID  - 10.1136/ebmed-2017-110721
DP  - 2017 Dec 01
TA  - Evidence Based Medicine
PG  - 215--216
VI  - 22
IP  - 6
4099  - http://ebm.bmj.com/content/22/6/215.short
4100  - http://ebm.bmj.com/content/22/6/215.full
SO  - Evid Based Med2017 Dec 01; 22